Back
Foghorn Therapeutics Vs. Novo Nordisk AS Industry Stock Comparison
Sell
6
FHTX
Foghorn Therapeutics
Last Price:
$5.12
Seasonality Move:
-15.18%
Sell
23
NVO
Novo Nordisk AS
Last Price:
$85.00
Seasonality Move:
6.92%
Sell
6
Foghorn Therapeutics (FHTX)
is a Sell
Is Foghorn Therapeutics a Buy, Sell or Hold?
-
The current Foghorn Therapeutics [FHTX] share price is $5.14. The Score for FHTX is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
-
FHTX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
23
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FHTX Stock Price Chart
What is Foghorn Therapeutics's stock price today?
-
The Foghorn Therapeutics share price today is $5.14Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FHTX is experiencing slight buying pressure.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $85.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.
FHTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.78 | Sell |
| Relative Strength Index (14 RSI): | 27.35 | Sell |
| Chaikin Money Flow: | 133127 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.71 - 7.91) | Sell |
| Bollinger Bands (100): | (6.36 - 8.96) | Sell |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.5 | Sell |
| Relative Strength Index (14 RSI): | 19.69 | Sell |
| Chaikin Money Flow: | 20899665 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (100.63 - 110.99) | Sell |
| Bollinger Bands (100): | (107.27 - 131.41) | Sell |
FHTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.42 | Sell |
| 20-day SMA: | 6.55 | Sell |
| 50-day SMA: | 7.49 | Sell |
| 200-day SMA: | 6.85 | Sell |
| 8-day EMA: | 5.47 | Sell |
| 20-day EMA: | 6.29 | Sell |
| 50-day EMA: | 7.13 | Sell |
| 200-day EMA: | 7 | Sell |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 104.71 | Sell |
| 20-day SMA: | 106.65 | Sell |
| 50-day SMA: | 109.28 | Sell |
| 200-day SMA: | 126.25 | Sell |
| 8-day EMA: | 102.07 | Sell |
| 20-day EMA: | 105.53 | Sell |
| 50-day EMA: | 110.02 | Sell |
| 200-day EMA: | 118.09 | Sell |
Foghorn Therapeutics Earnings Growth & FHTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and an increase next year of $0.45 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.
Foghorn Therapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk AS Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||